{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:17:42Z","timestamp":1771258662507,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T00:00:00Z","timestamp":1106697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00417-004-1093-6","type":"journal-article","created":{"date-parts":[[2005,1,25]],"date-time":"2005-01-25T11:24:08Z","timestamp":1106652248000},"page":"715-717","source":"Crossref","is-referenced-by-count":7,"title":["Retinal neovascularization during treatment with IGF-1 for insulin resistance syndrome"],"prefix":"10.1007","volume":"243","author":[{"given":"Hirokuni","family":"Kitamei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Kase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,1,26]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bjo.82.7.725","volume":"82","author":"E Chantelau","year":"1998","unstructured":"Chantelau E (1998) Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy. Br J Ophthalmol 82:725\u2013730","journal-title":"Br J Ophthalmol"},{"key":"1093_CR2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF00400229","volume":"36","author":"MB Grant","year":"1993","unstructured":"Grant MB, Mames RN, Fitzgerald C, Ellis EA, Aboufriekha M, Guy J (1993) Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia 36:282\u2013291","journal-title":"Diabetologia"},{"key":"1093_CR3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.2834824","volume":"240","author":"T Kadowaki","year":"1988","unstructured":"Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, Beitz L, MoKeon C, Taylor SI (1988) Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240:787\u2013790","journal-title":"Science"},{"key":"1093_CR4","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI200317455","volume":"111","author":"T Kondo","year":"2003","unstructured":"Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holtzenberger M, Kahn CR (2003) Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 111:1835\u20131842","journal-title":"J Clin Invest"},{"key":"1093_CR5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s004310050594","volume":"156","author":"G Kosztolanyi","year":"1997","unstructured":"Kosztolanyi G (1997) Leprechaunism\/Donohue syndrome\/insulin receptor gene mutations: a syndrome delineation story from clinicopathological description to molecular understanding. Eur J Pediatr 156:253\u2013255","journal-title":"Eur J Pediatr"},{"key":"1093_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1297\/cpe.3.Supple5_127","volume":"3","author":"H Kuzuya","year":"1994","unstructured":"Kuzuya H (1994) Long-term effects of insulin-like growth factor I (IGF-I) on insulin resistant diabetes. Clin Pediatr Endocrinol 3:127\u2013133","journal-title":"Clin Pediatr Endocrinol"},{"key":"1093_CR7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000050841","volume":"215","author":"XD Martin","year":"2001","unstructured":"Martin XD, Zenobi PD (2001) Type a syndrome of insulin resistance: anterior chamber anomalies of the eye and effects of insulin-like growth factor-I on the retina. Ophthalmologica 215:117\u2013123","journal-title":"Ophthalmologica"},{"key":"1093_CR8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jcem.83.2.4602","volume":"83","author":"J Nakae","year":"1998","unstructured":"Nakae J, Kato M, Murashita M, Shinohara N, Tajima T, Fujieda K (1998) Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism. J Clin Endocrinol Metab 83:542\u2013549","journal-title":"J Clin Endocrinol Metab"},{"key":"1093_CR9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1056-8727(03)00073-4","volume":"18","author":"BS Olsen","year":"2004","unstructured":"Olsen BS, Sjolie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB, Danish Study Group of Diabetes in Childhood (2004) The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. J Diabetes Complications 18:160\u2013164","journal-title":"J Diabetes Complications"},{"key":"1093_CR10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF00400998","volume":"34","author":"EJ Schoenle","year":"1991","unstructured":"Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER (1991) Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 34:675\u2013679","journal-title":"Diabetologia"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-004-1093-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-004-1093-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-004-1093-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:30:29Z","timestamp":1559071829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-004-1093-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,26]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1007\/s00417-004-1093-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,26]]}}}